Nancy Mace actually said...

If you have three companies making up the vast majority, that is not really competitive at all of an industry.

Do PBMs often exclude lower-cost generics in favor of high-cost branded drugs, effectively eliminating the benefit of the short patent on dr...

More competition in the market is better for every consumer. Less overreach from government, more competition in the private marketplace is ...

Do you believe they do this to cash in on drug rebates at the expense of patients?